Company page
Proqr Therapeutics N.v.
Proqr Therapeutics N.V. is a public company traded under the ticker PRQR in the American market, with a market capitalization of approximately $199 million. The company focuses on developing RNA medicines to treat genetic diseases. Proqr is committed to advancing its innovative therapies through research and development.
- Ticker
- PRQR:NASDAQ
- Asset type
- Stock
- Market cap
- $199.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD